Recently, the Food Safety and Standards Authority of India (FSSAI) has restricted enforcement activity against nutraceuticals and health supplement companies to only testing of products till new standards are notified.
"This move of Authority will bring a sigh of relief and take the industry forward which has succumbed to pressure of product approval for the last four years, and this decision now clears the hurdles," Indian Drug Manufacturers Association (IDMA) said in a statement.
The approval process was discontinued following a Supreme Court order on August 19 last year. In its order, the apex court had questioned the procedure followed for approvals by the food regulator.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
